Ramipril Capsule
FDA Label NDC 65841-657

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Ramipril (NDC 65841-657). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-655-06 in bottle of 30 Capsules

Ramipril Capsules, 1.25 mg

R_x only

30 Capsules

Ramipril Capsules, 1.25 mg (8b13d5be 600a 47c6 8348 Fcfef26ebe1b 01)

NDC 65841-656-01 in bottle of 100 Capsules

Ramipril Capsules, 2.5 mg

R_x only

100 Capsules

Ramipril Capsules, 2.5 mg (8b13d5be 600a 47c6 8348 Fcfef26ebe1b 02)

NDC 65841-657-01 in bottle of 100 Capsules

Ramipril Capsules, 5 mg

R_x only

100 Capsules

Ramipril Capsules, 5 mg (8b13d5be 600a 47c6 8348 Fcfef26ebe1b 03)

NDC 65841-658-01 in bottle of 100 Capsules

Ramipril Capsules, 10 mg

R_x only

100 Capsules

Ramipril Capsules, 10 mg (8b13d5be 600a 47c6 8348 Fcfef26ebe1b 04)

* Please review the disclaimer below.